Sean Bromley - Net Worth and Insider Trading

Sean Bromley Net Worth

The estimated net worth of Sean Bromley is at least $300 dollars as of 2024-11-13. Sean Bromley is the Director of Isracann Biosciences Inc and owns about 20,000 shares of Isracann Biosciences Inc (XCNQ:IPOT) stock worth over $300. Details can be seen in Sean Bromley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Bromley has not made any transactions after 2019-10-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sean Bromley

To

Sean Bromley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean Bromley owns 1 companies in total, including Isracann Biosciences Inc (XCNQ:IPOT) .

Click here to see the complete history of Sean Bromley’s form 4 insider trades.

Insider Ownership Summary of Sean Bromley

Ticker Comapny Transaction Date Type of Owner
XCNQ:IPOT Isracann Biosciences Inc 2019-10-21 Director

Sean Bromley Latest Holdings Summary

Sean Bromley currently owns a total of 1 stock. Sean Bromley owns 20,000 shares of Isracann Biosciences Inc (XCNQ:IPOT) as of October 21, 2019, with a value of $300.

Latest Holdings of Sean Bromley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XCNQ:IPOT Isracann Biosciences Inc 2019-10-21 20,000 0.02 300

Holding Weightings of Sean Bromley


Sean Bromley Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean Bromley has made a total of 0 transactions in Isracann Biosciences Inc (XCNQ:IPOT) over the past 5 years. The most-recent trade in Isracann Biosciences Inc is the acquisition of 10,000 shares on October 21, 2019, which cost Sean Bromley around $2,950.

Insider Trading History of Sean Bromley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean Bromley Trading Performance

GuruFocus tracks the stock performance after each of Sean Bromley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean Bromley is 31.71%. GuruFocus also compares Sean Bromley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean Bromley within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sean Bromley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sean Bromley

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 32.44 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 28.79 LIMIT LIMIT LIMIT LIMIT LIMIT

Sean Bromley Ownership Network

Ownership Network List of Sean Bromley

No Data

Ownership Network Relation of Sean Bromley

Insider Network Chart

Sean Bromley Owned Company Details

What does Isracann Biosciences Inc do?

Who are the key executives at Isracann Biosciences Inc?

Sean Bromley is the Director of Isracann Biosciences Inc.

Isracann Biosciences Inc (XCNQ:IPOT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Isracann Biosciences Inc (XCNQ:IPOT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Isracann Biosciences Inc (XCNQ:IPOT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Isracann Biosciences Inc (XCNQ:IPOT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Isracann Biosciences Inc Insider Transactions

No Available Data

Sean Bromley Mailing Address

Above is the net worth, insider trading, and ownership report for Sean Bromley. Currently GuruFocus does not have mailing address information for Sean Bromley.